Search Results for "Xarelto Vs Pradaxa"

01:11 EDT 28th March 2015 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

NICE Clears Pradaxa For DVT, Setting Up Another Clash With Xarelto

NICE has given the thumbs up to Boehringer Ingelheim's Pradaxa in deep vein thrombosis and pulmonary embolism, which means the drug is now set to battle Bayer's Xarelto for market share in this indica...

Boehringer submits Pradaxa antidote to regulators

A new product which can rapidly reverse the effects of Boehringer Ingelheim's (BI) anticoagulant Pradaxa has been filed with regulators in the US and Europe.The drug, idarucizumab, is the first to be ...

Portola's New Factor Xa Antidote Could Help Drive Xarelto And Eliquis Sales

By Jon Crowley: Background A few years ago, three new-generation anticoagulants were released in an attempt to improve upon and replace Coumadin. First released was Pradaxa, a direct thrombin inhibi...

Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com

PHILADELPHIA, Feb. 25, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Ba...

Legal-Bay Lawsuit Settlement Funding Reports Bayer and Johnson & Johnson to Pursue Further FDA Approvals for Xarelto while Cases against the Drug are Consolidated into Multidistrict Litigation

PHILADELPHIA, March 9, 2015 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reports that Bayer and Johnson & Johnson made a recent announcement that they will pursue ad...

Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use

Columbus, OH (PRWEB) November 22, 2014 A Xarelto lawsuit has been filed on behalf of a 72-year-old New York woman who is seeking $10 million in damages from the makers and marketers of the Xarelto...

Prescribe Blood Thinner Pradaxa With Caution, Study Warns

MONDAY, Nov. 3, 2014 (HealthDay News) -- Doctors may want to use caution when prescribing the blood thinner Pradaxa for a common irregular heart beat called atrial fibrillation. So say the authors ...

Legal-Bay Lawsuit Settlement Funding Reconfirms Commitment to Pradaxa Pre-Settlement and Settled Cases

LOS ANGELES, Nov. 6, 2014 /PRNewswire/ -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced today that they are reconfirming that they've increased their pre-settlement and settlement f...

Matching PubMed Articles

Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

A sensitive and accurate liquid chromatography method with mass spectrometry detection was developed and validated for the quantification of dabigatran (Pradaxa(®)) and rivaroxaban (Xarelto(®)). (13...

The New or Non-Vitamin K Antagonist Oral Anticoagulants: What Have We Learned Since Their Debut.

One of the major advances in the management of thrombosis is arguably the introduction of the new non-vitamin K antagonist oral anticoagulants (NOACs). These are small molecules, designed to directly ...

SPONTANEOUS CHOROIDAL HEMORRHAGE IN A PATIENT ON DABIGATRAN ETEXILATE (PRADAXA).

To report the first known case of spontaneous choroidals in association with a patient on dabigatran etexilate.

More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.

The number of patients on antithrombotic treatment due to atrial fibrillation and venous thromboembolism is increasing fast due to an aging population. A growing proportion will be treated with novel ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement